Cosciens Biopharma Appoints Peter Puccetti as Interim CEO
I'm PortAI, I can summarize articles.
Cosciens Biopharma Inc. has appointed Peter H. Puccetti as Interim CEO, replacing Anna Biehn. This leadership change is part of the company's efforts to strengthen operations and align with strategic priorities. The announcement was made on November 14, 2025, via GlobeNewswire.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments